Shuai Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shuai Li has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Jinwu Wang
Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine
6 shared publications Lei Qiang
Key Laboratory of Advanced Technologies of Materials (MOE) School of Materials Science and Engineering College of Medicine Southwest Jiaotong University Chengdu 610031 China
5 shared publicationsXue Yang
College of Medicine, Southwest Jiaotong University, No. 144 Jiaoda Road, Chengdu 610031, People’s Republic of China
5 shared publicationsXin Sun
Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhizaoju Rd, Shanghai 200011, People’s Republic of China
4 shared publicationsYihao Liu
Department of Orthopaedic Surgery Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200011 China
4 shared publicationsXiushuai Shang
Department of Orthopedics The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310003 China
3 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (37) , e71666
Biocompatible Gelatinized Starch as a Functional Modulator to Expand the Scope of Injectable Hydrogels
Injectable hydrogels used in tissue engineering and minimally invasive therapies are limited by insufficient biocompatibility, poor scalability, high costs, and inconsistent performance. Here, we introduce gelatinized starch, a common polysaccharide, as a versatile and economical building block to expand the existing repertoire of injectable hydrogel materials. Derived from native corn starch via heating and gelatinization, this biopolymer exhibits shear‐thinning, thixotropic, and thermoreversible sol–gel transition properties, key rheological characteristics essential for syringeability and in situ structural recovery. It readily integrates with photo‐crosslinkable (e.g., GelMA, HAMA, AlgMA) and ionically crosslinkable (e.g., alginate, chitosan) hydrogels. Rheological tests confirm that starch incorporation imparts excellent injectability, rapid gelation, and robust structural recovery. Bone marrow mesenchymal stem cells (BMSCs) encapsulated in starch‐based composite hydrogels maintained high viability, showed enhanced protein expression, and exhibited strong proliferation, which were modulated by starch concentration and cell seeding density. Notably, injection depth influenced post‐delivery cell viability within the hydrogel, whereas injection width had no significant effect. In a rat femoral condyle defect model, injection of a BMSC‐laden gelatinized starch hydrogel markedly promoted bone regeneration. Collectively, gelatinized starch overcomes key limitations of conventional injectable hydrogels, providing a cost‐effective, biocompatible, and functionally adaptable platform for cell delivery and tissue regeneration.
- 31 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (37) , e71666
Open AccessBiocompatible Gelatinized Starch as a Functional Modulator to Expand the Scope of Injectable Hydrogels
Injectable hydrogels used in tissue engineering and minimally invasive therapies are limited by insufficient biocompatibility, poor scalability, high costs, and inconsistent performance. Here, we introduce gelatinized starch, a common polysaccharide, as a versatile and economical building block to expand the existing repertoire of injectable hydrogel materials. Derived from native corn starch via heating and gelatinization, this biopolymer exhibits shear‐thinning, thixotropic, and thermoreversible sol–gel transition properties, key rheological characteristics essential for syringeability and in situ structural recovery. It readily integrates with photo‐crosslinkable (e.g., GelMA, HAMA, AlgMA) and ionically crosslinkable (e.g., alginate, chitosan) hydrogels. Rheological tests confirm that starch incorporation imparts excellent injectability, rapid gelation, and robust structural recovery. Bone marrow mesenchymal stem cells (BMSCs) encapsulated in starch‐based composite hydrogels maintained high viability, showed enhanced protein expression, and exhibited strong proliferation, which were modulated by starch concentration and cell seeding density. Notably, injection depth influenced post‐delivery cell viability within the hydrogel, whereas injection width had no significant effect. In a rat femoral condyle defect model, injection of a BMSC‐laden gelatinized starch hydrogel markedly promoted bone regeneration. Collectively, gelatinized starch overcomes key limitations of conventional injectable hydrogels, providing a cost‐effective, biocompatible, and functionally adaptable platform for cell delivery and tissue regeneration.
- Open Access
- 27 October 2025
- Published by Elsevier in Biomaterials
- Vol. 328, 123805
Dual-loaded BMSCs-Metformin microgels promote cartilage repair through combined anti-inflammatory, antioxidant, and regenerative effects
- 27 October 2025
- Published by Elsevier in Biomaterials
- Vol. 328, 123805
Open AccessDual-loaded BMSCs-Metformin microgels promote cartilage repair through combined anti-inflammatory, antioxidant, and regenerative effects
- Open Access
- 19 September 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (5) , 709-723
Evaluation of the 3D printable temperature-responsive shape-memory PLTG terpolymers for minimally invasive surgery
Three-dimensional (3D) printing has revolutionized the design and production of customized scaffolds, but the minimally invasive implantation of 3D-printed
- 19 September 2025
- Published by Zhejiang University Press in Bio-Design and Manufacturing
- Vol. 8 (5) , 709-723
Open AccessEvaluation of the 3D printable temperature-responsive shape-memory PLTG terpolymers for minimally invasive surgery
Three-dimensional (3D) printing has revolutionized the design and production of customized scaffolds, but the minimally invasive implantation of 3D-printed
- Top Cited PapersOpen Access
- 1 May 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 47, 152-169
Restoring tendon microenvironment in tendinopathy: Macrophage modulation and tendon regeneration with injectable tendon hydrogel and tendon-derived stem cells exosomes
Tendinopathy is a common musculoskeletal disorder in which a significant number of patients do not attain effective therapeutic outcomes. The extent of the inflammatory response and the dynamics of collagen synthesis metabolism are critical factors that influence the intrinsic self-repair capacity of tendons. However, the poor microenvironment within the tendon significantly impedes the self-repair process in tendinopathy. In this study, an injectable tendon-derived decellularized extracellular matrix (tdECM) hydrogel was utilized to treat tendinopathy. This hydrogel provides a more cytocompatible microenvironment while retaining certain bioactive factors of native tendon extracellular matrix (ECM), compared to collagen hydrogel. Notably, it was discovered for the first time that the tdECM hydrogel promotes M2 macrophage polarization, thereby exerting an anti-inflammatory effect in vivo. Furthermore, utilizing tdECM as a carrier for the sustained release of tendon-derived stem cells exosomes (TDSCs-Exos), our findings from both in vitro and in vivo studies indicate that the tdECM hydrogel, in conjunction with exosomes, demonstrated a pronounced synergistic enhancement in modulating inflammation, promoting M2 macrophage polarization, and facilitating tendon regeneration and repair efficacy. These results suggest its potential as a promising therapeutic strategy for tendon disorders.
- 1 May 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 47, 152-169
Top Cited PapersOpen AccessRestoring tendon microenvironment in tendinopathy: Macrophage modulation and tendon regeneration with injectable tendon hydrogel and tendon-derived stem cells exosomes
Tendinopathy is a common musculoskeletal disorder in which a significant number of patients do not attain effective therapeutic outcomes. The extent of the inflammatory response and the dynamics of collagen synthesis metabolism are critical factors that influence the intrinsic self-repair capacity of tendons. However, the poor microenvironment within the tendon significantly impedes the self-repair process in tendinopathy. In this study, an injectable tendon-derived decellularized extracellular matrix (tdECM) hydrogel was utilized to treat tendinopathy. This hydrogel provides a more cytocompatible microenvironment while retaining certain bioactive factors of native tendon extracellular matrix (ECM), compared to collagen hydrogel. Notably, it was discovered for the first time that the tdECM hydrogel promotes M2 macrophage polarization, thereby exerting an anti-inflammatory effect in vivo. Furthermore, utilizing tdECM as a carrier for the sustained release of tendon-derived stem cells exosomes (TDSCs-Exos), our findings from both in vitro and in vivo studies indicate that the tdECM hydrogel, in conjunction with exosomes, demonstrated a pronounced synergistic enhancement in modulating inflammation, promoting M2 macrophage polarization, and facilitating tendon regeneration and repair efficacy. These results suggest its potential as a promising therapeutic strategy for tendon disorders.
- Open Access
- 14 April 2025
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 11 (3) , 8557
3D printed GelMA/SA/CMCS hydrogel scaffolds containing cynomorium songaricum polysaccharide achieve critical bone defect repair
Critical bone defect repair remains a major challenge in orthopedic. Cynomorium songaricum polysaccharide (CSP), derived from the traditional medicinal plant Cynomorium songaricum Rupr in China, demonstrates excellent anti-inflammatory and osteogenic properties. Given these promising biological activities, we developed a novel therapeutic approach using a hydrogel composite scaffold incorporating CSP (GAC-C) for treating critical-sized bone defects. The composite scaffold was fabricated by embedding CSP into the methacrylated gelatin (GelMA)/sodium alginate(SA)/carboxymethyl chitosan (CMCS) blend via 3D printing technology. The structural, mechanical, and biological properties of GAC-C were characterized, and osteogenic performance was evaluated both in vitro with rat bone marrow stromal cells (rBMSCs) and in vivo using a critical-sized bone defect model. Results showed that the GAC-C scaffold demonstrated excellent biocompatibility, promoted osteogenic differentiation of rBMSCs, and enhanced bone integration and repair. Thus, the GAC-C scaffold shows potential for effectively repairing critical-sized bone defects.
- 14 April 2025
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 11 (3) , 8557
Open Access3D printed GelMA/SA/CMCS hydrogel scaffolds containing cynomorium songaricum polysaccharide achieve critical bone defect repair
Critical bone defect repair remains a major challenge in orthopedic. Cynomorium songaricum polysaccharide (CSP), derived from the traditional medicinal plant Cynomorium songaricum Rupr in China, demonstrates excellent anti-inflammatory and osteogenic properties. Given these promising biological activities, we developed a novel therapeutic approach using a hydrogel composite scaffold incorporating CSP (GAC-C) for treating critical-sized bone defects. The composite scaffold was fabricated by embedding CSP into the methacrylated gelatin (GelMA)/sodium alginate(SA)/carboxymethyl chitosan (CMCS) blend via 3D printing technology. The structural, mechanical, and biological properties of GAC-C were characterized, and osteogenic performance was evaluated both in vitro with rat bone marrow stromal cells (rBMSCs) and in vivo using a critical-sized bone defect model. Results showed that the GAC-C scaffold demonstrated excellent biocompatibility, promoted osteogenic differentiation of rBMSCs, and enhanced bone integration and repair. Thus, the GAC-C scaffold shows potential for effectively repairing critical-sized bone defects.
- Open Access
- 11 April 2025
- Published by Springer Nature in Research Square
CXCL12-ACKR3 Signaling Drives Fibrosis and Inflammation in Frozen Shoulder: A Single-Cell Guided Therapeutic Discovery
Frozen shoulder, a debilitating condition marked by chronic joint stiffness and pain, remains poorly understood due to unclear molecular drivers of its hallmark fibrosis and inflammation. Although fibroblast dysfunction contributes to FS pathology, specific pathogenic subsets remain unidentified. Through single-cell RNA sequencing of human synovial tissues, we discovered a distinct CXCL12-enriched fibroblast population (F1) driving disease progression via ACKR3 signaling. This axis exacerbated metalloproteinase (MMP)/tissue inhibitor of metalloproteinase (TIMP) dysregulation, promoting collagen overproduction and fibrotic niche formation. In vitro interventions demonstrated that both CXCL12 neutralization (Lit-927) and ACKR3 knockout effectively reduced pro-fibrotic responses by mitigating MMP/TIMP imbalance. Rat FS models recapitulated these findings, showing attenuated fibrosis following CXCL12 blockade. Our study establishes CXCL12-ACKR3 signaling as the central mechanism connecting fibroblast heterogeneity to extracellular matrix dysregulation in FS pathogenesis. These findings provide dual therapeutic strategies targeting ligand-receptor interactions for a condition currently managed only through symptomatic relief.
- 11 April 2025
- Published by Springer Nature in Research Square
Open AccessCXCL12-ACKR3 Signaling Drives Fibrosis and Inflammation in Frozen Shoulder: A Single-Cell Guided Therapeutic Discovery
Frozen shoulder, a debilitating condition marked by chronic joint stiffness and pain, remains poorly understood due to unclear molecular drivers of its hallmark fibrosis and inflammation. Although fibroblast dysfunction contributes to FS pathology, specific pathogenic subsets remain unidentified. Through single-cell RNA sequencing of human synovial tissues, we discovered a distinct CXCL12-enriched fibroblast population (F1) driving disease progression via ACKR3 signaling. This axis exacerbated metalloproteinase (MMP)/tissue inhibitor of metalloproteinase (TIMP) dysregulation, promoting collagen overproduction and fibrotic niche formation. In vitro interventions demonstrated that both CXCL12 neutralization (Lit-927) and ACKR3 knockout effectively reduced pro-fibrotic responses by mitigating MMP/TIMP imbalance. Rat FS models recapitulated these findings, showing attenuated fibrosis following CXCL12 blockade. Our study establishes CXCL12-ACKR3 signaling as the central mechanism connecting fibroblast heterogeneity to extracellular matrix dysregulation in FS pathogenesis. These findings provide dual therapeutic strategies targeting ligand-receptor interactions for a condition currently managed only through symptomatic relief.
- 12 October 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (48) , e2406891
Removal‐Free and Multicellular Suspension Bath‐Based 3D Bioprinting
Suspension bath‐based 3D bioprinting (SUB3BP) is effective in creating engineered vascular structures. The transfer of oxygen and nutrients via engineered vascular networks is necessary for tissue or organ survival and integration following transplantation. Existing SUB3BP techniques face challenges in fabricating hierarchical structures with multicellular organization, including issues related to suspension bath removal, restricted material choices, and low accuracy. A next‐generation SUB3BP technique that is removal‐free and multicellular is presented. A simple, storable, stable, and scalable starch hydrogel design leverages the diverse spectrum of hydrogels available for use in SUB3BP. Starch granules (8.1 µm) create vascular structures with minimal surface roughness (2.5 µm) that simulate more natural vessel walls compared to prior research. The development of cells and organoids, as well as the bioprinting of multicellular skin models with vasculature, demonstrates that starch suspension baths eliminate the removal process and have the potential for fabricating artificial tissue with a hierarchical structure and multicellular distribution.
- 12 October 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (48) , e2406891
Removal‐Free and Multicellular Suspension Bath‐Based 3D Bioprinting
Suspension bath‐based 3D bioprinting (SUB3BP) is effective in creating engineered vascular structures. The transfer of oxygen and nutrients via engineered vascular networks is necessary for tissue or organ survival and integration following transplantation. Existing SUB3BP techniques face challenges in fabricating hierarchical structures with multicellular organization, including issues related to suspension bath removal, restricted material choices, and low accuracy. A next‐generation SUB3BP technique that is removal‐free and multicellular is presented. A simple, storable, stable, and scalable starch hydrogel design leverages the diverse spectrum of hydrogels available for use in SUB3BP. Starch granules (8.1 µm) create vascular structures with minimal surface roughness (2.5 µm) that simulate more natural vessel walls compared to prior research. The development of cells and organoids, as well as the bioprinting of multicellular skin models with vasculature, demonstrates that starch suspension baths eliminate the removal process and have the potential for fabricating artificial tissue with a hierarchical structure and multicellular distribution.
- 13 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (38) , 50175-50187
Near-Infrared Stimuli-Responsive Hydrogel Promotes Cell Migration for Accelerated Diabetic Wound Healing
Diabetic wound healing including diabetic foot ulcers is a major clinical challenge, which could bring an increased level of mortality and morbidity. However, conventional wound dressings exhibit limited healing efficacy due to their lack of active modulation for the healing process. Here, a near-infrared (NIR) stimuli-responsive composite hydrogel dressing with the synergistic effect of both mechanical contraction and epithelial-mesenchymal transition (EMT) was developed to facilitate cell migration and vascularization for diabetic wound healing. In the methacrylated gelatin-based composite hydrogel, N-isopropylacrylamide and polydopamine nanoparticles were incorporated to endow the composite hydrogel with thermosensitive and photothermal properties. Linagliptin (LIN) was loaded into the composite hydrogel, and the drug release rate could be controlled by NIR laser irradiation. NIR-triggered on-demand active contraction of wound area and LIN release for biological stimulation were potentially realized in this responsive system due to the thermally induced sol-gel transition of the composite hydrogel. The release of loaded LIN could effectively promote cell migration by activating EMT and enhancing angiogenesis. In the full-thickness skin defect model, the LIN-loaded composite hydrogel with NIR laser irradiation had the highest wound closure rate as compared with the pure hydrogel and LIN-loaded hydrogel groups. Therefore, this composite hydrogel can serve as an excellent platform for promoting wound healing and will find more practical value in clinical treatment.
- 13 September 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (38) , 50175-50187
Near-Infrared Stimuli-Responsive Hydrogel Promotes Cell Migration for Accelerated Diabetic Wound Healing
Diabetic wound healing including diabetic foot ulcers is a major clinical challenge, which could bring an increased level of mortality and morbidity. However, conventional wound dressings exhibit limited healing efficacy due to their lack of active modulation for the healing process. Here, a near-infrared (NIR) stimuli-responsive composite hydrogel dressing with the synergistic effect of both mechanical contraction and epithelial-mesenchymal transition (EMT) was developed to facilitate cell migration and vascularization for diabetic wound healing. In the methacrylated gelatin-based composite hydrogel, N-isopropylacrylamide and polydopamine nanoparticles were incorporated to endow the composite hydrogel with thermosensitive and photothermal properties. Linagliptin (LIN) was loaded into the composite hydrogel, and the drug release rate could be controlled by NIR laser irradiation. NIR-triggered on-demand active contraction of wound area and LIN release for biological stimulation were potentially realized in this responsive system due to the thermally induced sol-gel transition of the composite hydrogel. The release of loaded LIN could effectively promote cell migration by activating EMT and enhancing angiogenesis. In the full-thickness skin defect model, the LIN-loaded composite hydrogel with NIR laser irradiation had the highest wound closure rate as compared with the pure hydrogel and LIN-loaded hydrogel groups. Therefore, this composite hydrogel can serve as an excellent platform for promoting wound healing and will find more practical value in clinical treatment.
- Open Access
- 24 July 2023
- Published by Wiley in Medcomm – Biomaterials and Applications
- Vol. 2 (3)
Recent advances in 3D printing sacrificial templates for fabricating engineered vasculature
Fabricating engineered vasculature within biological scaffolds is one of the most common strategies to maintain high cell viability before implantation. Many studies have been conducted from the aspects of the manufacturing process, materials science, and cell biology to fabricate engineered vasculature with the aim of enhancing the integration between scaffold and host. Among them, the method of combining three‐dimensional (3D) printing and sacrifice‐based technique has attracted extensive attention. Taking advantage of 3D printing, the method of separating the printed sacrificial template from the biological scaffold to form a 3D channel has become a widely used approach to advance the engineered vasculature. With the development of 3D printing techniques and material science, numerous sacrificial materials have shown their potential in fabricating engineered vasculature. However, several issues remain in this multimethod design, including, but not limited to, the printing process, removal method of sacrificial material, and cell seeding method. This review aims to summarize recent strategies for 3D printing sacrificial templates for fabricating engineered vasculature. The pros and cons of sacrificial materials used in these studies are analyzed. Future perspectives are proposed to fabricate biomimetic‐engineered vasculature. Flexible fabrication processes and materials should be advanced to support the 3D printing of sacrificial templates.
- 24 July 2023
- Published by Wiley in Medcomm – Biomaterials and Applications
- Vol. 2 (3)
Open AccessRecent advances in 3D printing sacrificial templates for fabricating engineered vasculature
Fabricating engineered vasculature within biological scaffolds is one of the most common strategies to maintain high cell viability before implantation. Many studies have been conducted from the aspects of the manufacturing process, materials science, and cell biology to fabricate engineered vasculature with the aim of enhancing the integration between scaffold and host. Among them, the method of combining three‐dimensional (3D) printing and sacrifice‐based technique has attracted extensive attention. Taking advantage of 3D printing, the method of separating the printed sacrificial template from the biological scaffold to form a 3D channel has become a widely used approach to advance the engineered vasculature. With the development of 3D printing techniques and material science, numerous sacrificial materials have shown their potential in fabricating engineered vasculature. However, several issues remain in this multimethod design, including, but not limited to, the printing process, removal method of sacrificial material, and cell seeding method. This review aims to summarize recent strategies for 3D printing sacrificial templates for fabricating engineered vasculature. The pros and cons of sacrificial materials used in these studies are analyzed. Future perspectives are proposed to fabricate biomimetic‐engineered vasculature. Flexible fabrication processes and materials should be advanced to support the 3D printing of sacrificial templates.
- Open Access
- 10 May 2023
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 9 (5) , 34-53
Swelling compensation of engineered vasculature fabricated by additive manufacturing and sacrifice-based technique using thermoresponsive hydrogel
Engineered vasculature is widely employed to maintain the cell viability within in vitro tissues. A variety of fabrication techniques for engineered vasculature have been explored, with combination of additive manufacturing with a sacrifice-based technique being the most common approach. However, the size deformation of vasculature caused by the swelling of sacrificial materials remains unaddressed. In this study, Pluronic F-127 (PF-127), the most widely used sacrificial material, was employed to study the deformation of the vasculature. Then, a thermoresponsive hydrogel comprising poly(N-isopropylacrylamide) (PNIPAM) and gelatin methacrylate (GelMA) was used to induce volume shrinkage at 37°C to compensate for the deformation of vasculature caused by the swelling of a three-dimensional (3D)- printed sacrificial template, and to generate vasculature of a smaller size than that after deformation. Our results showed that the vasculature diameter increased after the sacrificial template was removed, whereas it decreased to the designed diameter after the volume shrinkage. Human umbilical vein endothelial cells (HUVECs) formed an endothelial monolayer in the engineered vasculature. Osteosarcoma cells (OCs) were loaded into a hierarchical vasculature within the thermoresponsive hydrogel to investigate the interaction between HUVECs and OCs. New blood vessel infiltration was observed within the lumen of the engineered vasculature after in vivo subcutaneous implantation for 4 weeks. In addition, engineered vasculature was implanted in a rat ischemia model to further study the function of engineered vasculature for blood vessel infiltration. This study presents a small method aiming to accurately create engineered vasculature by additive manufacturing and a sacrificebased technique.
- 10 May 2023
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 9 (5) , 34-53
Open AccessSwelling compensation of engineered vasculature fabricated by additive manufacturing and sacrifice-based technique using thermoresponsive hydrogel
Engineered vasculature is widely employed to maintain the cell viability within in vitro tissues. A variety of fabrication techniques for engineered vasculature have been explored, with combination of additive manufacturing with a sacrifice-based technique being the most common approach. However, the size deformation of vasculature caused by the swelling of sacrificial materials remains unaddressed. In this study, Pluronic F-127 (PF-127), the most widely used sacrificial material, was employed to study the deformation of the vasculature. Then, a thermoresponsive hydrogel comprising poly(N-isopropylacrylamide) (PNIPAM) and gelatin methacrylate (GelMA) was used to induce volume shrinkage at 37°C to compensate for the deformation of vasculature caused by the swelling of a three-dimensional (3D)- printed sacrificial template, and to generate vasculature of a smaller size than that after deformation. Our results showed that the vasculature diameter increased after the sacrificial template was removed, whereas it decreased to the designed diameter after the volume shrinkage. Human umbilical vein endothelial cells (HUVECs) formed an endothelial monolayer in the engineered vasculature. Osteosarcoma cells (OCs) were loaded into a hierarchical vasculature within the thermoresponsive hydrogel to investigate the interaction between HUVECs and OCs. New blood vessel infiltration was observed within the lumen of the engineered vasculature after in vivo subcutaneous implantation for 4 weeks. In addition, engineered vasculature was implanted in a rat ischemia model to further study the function of engineered vasculature for blood vessel infiltration. This study presents a small method aiming to accurately create engineered vasculature by additive manufacturing and a sacrificebased technique.